Colitis, Ulcerative - Drug therapy
Research News and Information

Sunday, November 22, 2009

[Extraintestinal manifestations in inflammatory bowel disease]

17 Oct 2009 Extraintestinal manifestations are relatively common in chronic inflammatory bowel disease and affect joints, skin, eyes and bile ducts. The most frequent rheumatologic manifestations are peripheral arthritis and axial arthropathies. Erythema ... Read more...

Balsalazide: a novel 5-aminosalicylate prodrug for the treatment of active ulcerative colitis.

29 Sep 2009 BACKGROUND: 5-Aminosalicylate (5-ASA) agents are the mainstay of oral therapy for ulcerative colitis (UC). Balsalazide, a prodrug of 5-ASA, has recently been approved for the treatment of UC. OBJECTIVE: To summarize current data on balsalazide and ... Read more...

[TNF-alpha blocking therapy in chronic inflammatory bowel disease]

18 Sep 2009 The introduction of TNF-alpha blocking therapy has produced a dramatic change in the treatment of therapy resistant patients with inflammatory bowel disease. Both infliximab and adalimumab are effective in moderately severe and severe Crohn's ... Read more...

Latest indexed articles for 'Colitis, Ulcerative - Drug therapy'

These are the very latest articles for this heading:

• [Extraintestinal manifestations in inflammatory bowel disease] 17 Oct 2009
• Balsalazide: a novel 5-aminosalicylate prodrug for the treatment of active ulcerative colitis. 29 Sep 2009
• [TNF-alpha blocking therapy in chronic inflammatory bowel disease] 18 Sep 2009
• Early aggressive therapy for severe extensive ulcerative colitis. 5 Sep 2009
• Emerging drugs for the treatment of ulcerative colitis. 30 Aug 2009
• Open-label study of adalimumab in patients with ulcerative colitis including those with prior loss of response or intolerance to infliximab. 30 Aug 2009
• Risk factors and characteristics of extent progression in ulcerative colitis. 30 Aug 2009
• Crohn's disease, hepatosplenic T-cell lymphoma and no biological therapy: are we barking up the wrong tree? 30 Aug 2009
• Case of linear IgA bullous dermatosis-involved ulcerative colitis. 30 Aug 2009
• Infliximab-induced reactivated Langerhan's cell histiocytosis in a patient with ulcerative colitis. 30 Aug 2009
• HE3286: a novel synthetic steroid as an oral treatment for autoimmune disease. 30 Aug 2009
• TNF alpha inhibition as treatment modality for certain rheumatologic and gastrointestinal diseases. 30 Aug 2009
• Drugs for inflammatory bowel disease. 30 Aug 2009
• Autoimmune hemolytic anemia associated with ulcerative colitis: response to infliximab. 30 Aug 2009
• Is keeping the colon the ultimate marker of success in ulcerative colitis? 26 Aug 2009
• Mutagenicity and potential carcinogenicity of thiopurine treatment in patients with inflammatory bowel disease. 23 Aug 2009
• Adalimumab in ulcerative colitis: two cases of mucosal healing and clinical response at two years. 12 Aug 2009
• Remission of histiocytic ulcerative colitis in Boxer dogs correlates with eradication of invasive intramucosal Escherichia coli. 9 Aug 2009
• Management of acute severe ulcerative colitis. 30 Jul 2009
• Role of medical rescue therapy in the management of acute severe ulcerative colitis: the surgical perspective. 30 Jul 2009

See a longer list of these articles.

Technical information about 'Colitis, Ulcerative'

Definition: Inflammation of the COLON that is predominantly confined to the MUCOSA. Its major symptoms include DIARRHEA, rectal BLEEDING, the passage of MUCUS, and ABDOMINAL PAIN.

Descriptor UI: D003093

Alternative terms: Colitis, Ulcerative; Ulcerative Colitis;

Allowable Qualifiers: blood; cerebrospinal fluid; chemically induced; classification; complications; congenital; diagnosis; diet therapy; drug therapy; economics; embryology; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; radiotherapy; rehabilitation; surgery; therapy; urine; veterinary; ultrasonography; virology;

Tree Number: C06.405.205.265.231; C06.405.205.731.249; C06.405.469.158.188.231; C06.405.469.432.249;

Technical Notes: usually chronic so do not coord with CHRONIC DISEASE